Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ETEC | 20.97 | 0.49 | +2.39% |
| iShares Breakthrough Envirtl Sol ETF | |||
| WBIY | 30.36 | 0.10 | +0.32% |
| WBI Power Factor® High Dividend ETF | |||
| SPIP | 25.95 | 0.01 | +0.04% |
| SPDR® Portfolio TIPS ETF | |||
| FGDL | 44.61 | 0.01 | +0.02% |
| Franklin Responsibly Sourced Gold ETF | |||
| CADNZD | 1.22 | -0.00 | -0.32% |
| Canadian Dollar - New Zealand Dollar | |||
A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with NERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then NERV could also see price increases.
| Ticker / NAME | Correlation To ASPHF | 1D Price Change % | ||
|---|---|---|---|---|
| ASPHF | 100% | N/A | ||
| NERV - ASPHF | 44% Loosely correlated | N/A | ||
| GPCR - ASPHF | 31% Poorly correlated | -1.43% | ||
| NURPF - ASPHF | 30% Poorly correlated | N/A | ||
| PYPD - ASPHF | 24% Poorly correlated | -4.74% | ||
| GOSS - ASPHF | 24% Poorly correlated | +2.41% | ||
More | ||||